A novel type of colistin resistance genes selected from random sequence space

Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS genetics 2021-01, Vol.17 (1), p.e1009227, Article 1009227
Hauptverfasser: Knopp, Michael, Babina, Arianne M., Gudmundsdottir, Jonina S., Douglass, Martin, Trent, M. Stephen, Andersson, Dan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page e1009227
container_title PLoS genetics
container_volume 17
creator Knopp, Michael
Babina, Arianne M.
Gudmundsdottir, Jonina S.
Douglass, Martin
Trent, M. Stephen
Andersson, Dan
description Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura. Author summary We expressed over 100 million randomly generated DNA sequences in Escherichia coli and selected 6 variants that encode peptides that provide resistance to the last-resort antibiotic colistin. We show that the selected peptides are auxiliary activators of the two-component system PmrAB, and that resistance is mediated via modifications of the cell envelope causing decreased antibiotic uptake. This is the first example where random expression libraries have been employed to select for peptides that perform an activating function by direct peptide-protein interactions in vivo, adding support to the idea that non-coding DNA can serve as a s
doi_str_mv 10.1371/journal.pgen.1009227
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_gale_infotracmisc_A650814638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A650814638</galeid><doaj_id>oai_doaj_org_article_5ce6b9536d03489d8d6ceb49d2f199c8</doaj_id><sourcerecordid>A650814638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c711t-9d8e8ae0127dda70dae1c81c4a3deab99589325e518de51b743164799e3700da3</originalsourceid><addsrcrecordid>eNqVkl2L1DAUhoso7rr6D0QKgiA6Y9KkTXMjDOPXwOqCH3sb0uR0JkMn6TbprvvvTbfjMAUvVgLJIXne9xzCmyTPMZpjwvC7res7K5t5uwY7xwjxLGMPklOc52TGKKIPj-qT5In3W4RIXnL2ODkhhGLMSHGafF2k1l1Dk4bbFlJXp8o1xgdj0w58LKRVkMYO4FMPDagAOq07t0s7aXU8PFz1MDC-lQqeJo9q2Xh4tj_Pkl-fPv5cfpmdX3xeLRfnM8UwDjOuSyglIJwxrSVDWgJWJVZUEg2y4jyOSbIcclzquFWMElxQxjkQhiJNzpLV6Kud3Iq2MzvZ3Qonjbi7cN1ayC4Y1YDIFRQVz0mhEaFl7KwLBRXlOqsx56qMXm9HL38DbV9N3D6Yy8WdW98LSijL8oi_H_HI7kArsKGTzUQ1fbFmI9buWjDGUZbjaPByNFjLOJ6xtYuY2hmvxKLIUYlpQYap5v-g4tKwM8pZqE28nwheTwSRCfA7rGXvvVj9-P4f7Lf7sxeXU_bVEbsB2YSNd00fjLN-CtIRVJ3zvoP68H8YiSHdYp9uMaRb7NMdZS-O__4g-hvnCJQjcAOVq70yQzQPGEKoQCWieRErRJcmyGGypettiNI395eSP7eNFqA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A novel type of colistin resistance genes selected from random sequence space</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SWEPUB Freely available online</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Knopp, Michael ; Babina, Arianne M. ; Gudmundsdottir, Jonina S. ; Douglass, Martin ; Trent, M. Stephen ; Andersson, Dan</creator><contributor>Buchrieser, Carmen</contributor><creatorcontrib>Knopp, Michael ; Babina, Arianne M. ; Gudmundsdottir, Jonina S. ; Douglass, Martin ; Trent, M. Stephen ; Andersson, Dan ; Buchrieser, Carmen</creatorcontrib><description>Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura. Author summary We expressed over 100 million randomly generated DNA sequences in Escherichia coli and selected 6 variants that encode peptides that provide resistance to the last-resort antibiotic colistin. We show that the selected peptides are auxiliary activators of the two-component system PmrAB, and that resistance is mediated via modifications of the cell envelope causing decreased antibiotic uptake. This is the first example where random expression libraries have been employed to select for peptides that perform an activating function by direct peptide-protein interactions in vivo, adding support to the idea that non-coding DNA can serve as a substrate for de novo gene evolution. Additionally, the described peptides expand the narrow list of colistin resistance genes and further analyses of clinical isolates will be necessary to determine if similar resistance determinants have evolved in natura.</description><identifier>ISSN: 1553-7404</identifier><identifier>ISSN: 1553-7390</identifier><identifier>EISSN: 1553-7404</identifier><identifier>DOI: 10.1371/journal.pgen.1009227</identifier><identifier>PMID: 33411736</identifier><language>eng</language><publisher>SAN FRANCISCO: Public Library Science</publisher><subject>Anti-Bacterial Agents - adverse effects ; Bacterial Proteins - genetics ; Biology and Life Sciences ; Colistin ; Colistin - adverse effects ; Colistin - pharmacology ; Dosage and administration ; Drug resistance in microorganisms ; Drug Resistance, Bacterial - genetics ; Drug therapy ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli infections ; Genetic aspects ; Genetics &amp; Heredity ; Identification and classification ; Life Sciences &amp; Biomedicine ; Lipid A - genetics ; Lipopolysaccharides - genetics ; Medicine and Health Sciences ; Microbial Sensitivity Tests ; Open Reading Frames - genetics ; Peptides ; Research and analysis methods ; Science &amp; Technology ; Transcription Factors - genetics</subject><ispartof>PLoS genetics, 2021-01, Vol.17 (1), p.e1009227, Article 1009227</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Knopp et al 2021 Knopp et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>23</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000608045600004</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c711t-9d8e8ae0127dda70dae1c81c4a3deab99589325e518de51b743164799e3700da3</citedby><cites>FETCH-LOGICAL-c711t-9d8e8ae0127dda70dae1c81c4a3deab99589325e518de51b743164799e3700da3</cites><orcidid>0000-0002-4635-8396 ; 0000-0001-6640-2174 ; 0000-0002-8218-3263 ; 0000-0002-4500-4078 ; 0000-0001-6134-1800</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790251/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790251/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,553,728,781,785,865,886,2103,2115,2929,27929,27930,39263,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33411736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-434725$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><contributor>Buchrieser, Carmen</contributor><creatorcontrib>Knopp, Michael</creatorcontrib><creatorcontrib>Babina, Arianne M.</creatorcontrib><creatorcontrib>Gudmundsdottir, Jonina S.</creatorcontrib><creatorcontrib>Douglass, Martin</creatorcontrib><creatorcontrib>Trent, M. Stephen</creatorcontrib><creatorcontrib>Andersson, Dan</creatorcontrib><title>A novel type of colistin resistance genes selected from random sequence space</title><title>PLoS genetics</title><addtitle>PLOS GENET</addtitle><addtitle>PLoS Genet</addtitle><description>Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura. Author summary We expressed over 100 million randomly generated DNA sequences in Escherichia coli and selected 6 variants that encode peptides that provide resistance to the last-resort antibiotic colistin. We show that the selected peptides are auxiliary activators of the two-component system PmrAB, and that resistance is mediated via modifications of the cell envelope causing decreased antibiotic uptake. This is the first example where random expression libraries have been employed to select for peptides that perform an activating function by direct peptide-protein interactions in vivo, adding support to the idea that non-coding DNA can serve as a substrate for de novo gene evolution. Additionally, the described peptides expand the narrow list of colistin resistance genes and further analyses of clinical isolates will be necessary to determine if similar resistance determinants have evolved in natura.</description><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Bacterial Proteins - genetics</subject><subject>Biology and Life Sciences</subject><subject>Colistin</subject><subject>Colistin - adverse effects</subject><subject>Colistin - pharmacology</subject><subject>Dosage and administration</subject><subject>Drug resistance in microorganisms</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Drug therapy</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli infections</subject><subject>Genetic aspects</subject><subject>Genetics &amp; Heredity</subject><subject>Identification and classification</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Lipid A - genetics</subject><subject>Lipopolysaccharides - genetics</subject><subject>Medicine and Health Sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Open Reading Frames - genetics</subject><subject>Peptides</subject><subject>Research and analysis methods</subject><subject>Science &amp; Technology</subject><subject>Transcription Factors - genetics</subject><issn>1553-7404</issn><issn>1553-7390</issn><issn>1553-7404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><sourceid>D8T</sourceid><sourceid>DOA</sourceid><recordid>eNqVkl2L1DAUhoso7rr6D0QKgiA6Y9KkTXMjDOPXwOqCH3sb0uR0JkMn6TbprvvvTbfjMAUvVgLJIXne9xzCmyTPMZpjwvC7res7K5t5uwY7xwjxLGMPklOc52TGKKIPj-qT5In3W4RIXnL2ODkhhGLMSHGafF2k1l1Dk4bbFlJXp8o1xgdj0w58LKRVkMYO4FMPDagAOq07t0s7aXU8PFz1MDC-lQqeJo9q2Xh4tj_Pkl-fPv5cfpmdX3xeLRfnM8UwDjOuSyglIJwxrSVDWgJWJVZUEg2y4jyOSbIcclzquFWMElxQxjkQhiJNzpLV6Kud3Iq2MzvZ3Qonjbi7cN1ayC4Y1YDIFRQVz0mhEaFl7KwLBRXlOqsx56qMXm9HL38DbV9N3D6Yy8WdW98LSijL8oi_H_HI7kArsKGTzUQ1fbFmI9buWjDGUZbjaPByNFjLOJ6xtYuY2hmvxKLIUYlpQYap5v-g4tKwM8pZqE28nwheTwSRCfA7rGXvvVj9-P4f7Lf7sxeXU_bVEbsB2YSNd00fjLN-CtIRVJ3zvoP68H8YiSHdYp9uMaRb7NMdZS-O__4g-hvnCJQjcAOVq70yQzQPGEKoQCWieRErRJcmyGGypettiNI395eSP7eNFqA</recordid><startdate>20210107</startdate><enddate>20210107</enddate><creator>Knopp, Michael</creator><creator>Babina, Arianne M.</creator><creator>Gudmundsdottir, Jonina S.</creator><creator>Douglass, Martin</creator><creator>Trent, M. Stephen</creator><creator>Andersson, Dan</creator><general>Public Library Science</general><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISN</scope><scope>ISR</scope><scope>5PM</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4635-8396</orcidid><orcidid>https://orcid.org/0000-0001-6640-2174</orcidid><orcidid>https://orcid.org/0000-0002-8218-3263</orcidid><orcidid>https://orcid.org/0000-0002-4500-4078</orcidid><orcidid>https://orcid.org/0000-0001-6134-1800</orcidid></search><sort><creationdate>20210107</creationdate><title>A novel type of colistin resistance genes selected from random sequence space</title><author>Knopp, Michael ; Babina, Arianne M. ; Gudmundsdottir, Jonina S. ; Douglass, Martin ; Trent, M. Stephen ; Andersson, Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c711t-9d8e8ae0127dda70dae1c81c4a3deab99589325e518de51b743164799e3700da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Bacterial Proteins - genetics</topic><topic>Biology and Life Sciences</topic><topic>Colistin</topic><topic>Colistin - adverse effects</topic><topic>Colistin - pharmacology</topic><topic>Dosage and administration</topic><topic>Drug resistance in microorganisms</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Drug therapy</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli infections</topic><topic>Genetic aspects</topic><topic>Genetics &amp; Heredity</topic><topic>Identification and classification</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Lipid A - genetics</topic><topic>Lipopolysaccharides - genetics</topic><topic>Medicine and Health Sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Open Reading Frames - genetics</topic><topic>Peptides</topic><topic>Research and analysis methods</topic><topic>Science &amp; Technology</topic><topic>Transcription Factors - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knopp, Michael</creatorcontrib><creatorcontrib>Babina, Arianne M.</creatorcontrib><creatorcontrib>Gudmundsdottir, Jonina S.</creatorcontrib><creatorcontrib>Douglass, Martin</creatorcontrib><creatorcontrib>Trent, M. Stephen</creatorcontrib><creatorcontrib>Andersson, Dan</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knopp, Michael</au><au>Babina, Arianne M.</au><au>Gudmundsdottir, Jonina S.</au><au>Douglass, Martin</au><au>Trent, M. Stephen</au><au>Andersson, Dan</au><au>Buchrieser, Carmen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel type of colistin resistance genes selected from random sequence space</atitle><jtitle>PLoS genetics</jtitle><stitle>PLOS GENET</stitle><addtitle>PLoS Genet</addtitle><date>2021-01-07</date><risdate>2021</risdate><volume>17</volume><issue>1</issue><spage>e1009227</spage><pages>e1009227-</pages><artnum>1009227</artnum><issn>1553-7404</issn><issn>1553-7390</issn><eissn>1553-7404</eissn><abstract>Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura. Author summary We expressed over 100 million randomly generated DNA sequences in Escherichia coli and selected 6 variants that encode peptides that provide resistance to the last-resort antibiotic colistin. We show that the selected peptides are auxiliary activators of the two-component system PmrAB, and that resistance is mediated via modifications of the cell envelope causing decreased antibiotic uptake. This is the first example where random expression libraries have been employed to select for peptides that perform an activating function by direct peptide-protein interactions in vivo, adding support to the idea that non-coding DNA can serve as a substrate for de novo gene evolution. Additionally, the described peptides expand the narrow list of colistin resistance genes and further analyses of clinical isolates will be necessary to determine if similar resistance determinants have evolved in natura.</abstract><cop>SAN FRANCISCO</cop><pub>Public Library Science</pub><pmid>33411736</pmid><doi>10.1371/journal.pgen.1009227</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-4635-8396</orcidid><orcidid>https://orcid.org/0000-0001-6640-2174</orcidid><orcidid>https://orcid.org/0000-0002-8218-3263</orcidid><orcidid>https://orcid.org/0000-0002-4500-4078</orcidid><orcidid>https://orcid.org/0000-0001-6134-1800</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7404
ispartof PLoS genetics, 2021-01, Vol.17 (1), p.e1009227, Article 1009227
issn 1553-7404
1553-7390
1553-7404
language eng
recordid cdi_gale_infotracmisc_A650814638
source MEDLINE; DOAJ Directory of Open Access Journals; SWEPUB Freely available online; Public Library of Science (PLoS) Journals Open Access; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Anti-Bacterial Agents - adverse effects
Bacterial Proteins - genetics
Biology and Life Sciences
Colistin
Colistin - adverse effects
Colistin - pharmacology
Dosage and administration
Drug resistance in microorganisms
Drug Resistance, Bacterial - genetics
Drug therapy
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli infections
Genetic aspects
Genetics & Heredity
Identification and classification
Life Sciences & Biomedicine
Lipid A - genetics
Lipopolysaccharides - genetics
Medicine and Health Sciences
Microbial Sensitivity Tests
Open Reading Frames - genetics
Peptides
Research and analysis methods
Science & Technology
Transcription Factors - genetics
title A novel type of colistin resistance genes selected from random sequence space
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A40%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20type%20of%20colistin%20resistance%20genes%20selected%20from%20random%20sequence%20space&rft.jtitle=PLoS%20genetics&rft.au=Knopp,%20Michael&rft.date=2021-01-07&rft.volume=17&rft.issue=1&rft.spage=e1009227&rft.pages=e1009227-&rft.artnum=1009227&rft.issn=1553-7404&rft.eissn=1553-7404&rft_id=info:doi/10.1371/journal.pgen.1009227&rft_dat=%3Cgale_pubme%3EA650814638%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33411736&rft_galeid=A650814638&rft_doaj_id=oai_doaj_org_article_5ce6b9536d03489d8d6ceb49d2f199c8&rfr_iscdi=true